Concepedia

Lisa A. Hammond-Thelin

LA

2

Publications

57

Citations

2

H-Index

2007

Active since

Affiliations

Eli Lilly (United States)(Current)

Lisa A. Hammond-Thelin is an author at Eli Lilly (United States) specializing in oncology, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2007–2010

2

Publications

2

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

Chris H. Takimoto, Lisa A. Hammond-Thelin, Jane E. Latz et al. · Clinical Cancer Research · 2007 · 47 citations

Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies

Lisa A. Hammond-Thelin, Melanie B. Thomas, Michiko Iwasaki et al. · Investigational New Drugs · 2010 · 10 citations · Full text

, , +9

Rows per page

1–2 of 2